(Q34249428)

31 July 2017

1 reference

title

Developments in the control of testicular function (English)

1 reference

31 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1377467

20 September 2022

sex organ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1377467

20 September 2022

genitourinary system

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1377467

20 September 2022

physiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1377467

glyco-Lutropin [extracellular region]

20 September 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1377467

follicle stimulating hormone

20 September 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1377467

20 September 2022

contraceptive agents

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1377467

20 September 2022

male contraceptive agent

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1377467

20 September 2022

pituitary gonadotropins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1377467

20 September 2022

author name string

R. S. Swerdloff

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1377467

20 September 2022

C. Wang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1377467

20 September 2022

S. Bhasin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1377467

20 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1377467

20 September 2022

publication date

1 April 1992

1 reference

Bailliere's clinical endocrinology and metabolism

31 July 2017

published in

1 reference

31 July 2017

volume

6

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

451-483

1 reference

Suppression of plasma gonadotropins and testosterone in adult male monkeys (Macaca fascicularis) by a potent inhibitory analog of gonadotropin-releasing hormone

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Testosterone supplementation attenuates the antifertility effects of an LHRH agonist in male rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

A comparison of the suppressive effects of testosterone and a potent new gonadotropin-releasing hormone antagonist on gonadotropin and inhibin levels in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Effect of age, castration, and testosterone replacement on the development and restoration of canine benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Mechanisms of gonadotropin-releasing hormone agonist action in the human male

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Does constant infusion of gonadotropin-releasing hormone agonist lead to greater suppression of gonadal function in man than its intermittent administration?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in men: effects of long term treatment with GnRH agonist infusion and androgen

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Acute and chronic effects of a gonadotrophin-releasing hormone antagonist on pituitary and testicular function in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Study of medroxyprogesterone acetate and testosterone enanthate as a male contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Effect of a new 5 alpha-reductase inhibitor on size, histologic characteristics, and androgen concentrations of the canine prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Adrenergic and Cholinergic Receptors in the Human Prostate, Prostatic Capsule and Bladder Neck

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

A Placebo-controlled Double-blind Study of the Effect of Phenoxybenzamine in Benign Prostatic Obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

The effect of exogenous testosterone upon serum FSH and LH concentrations in normal males

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Absence of gonadotropin-releasing hormone receptors in human gonadal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

The cycle of the seminiferous epithelium in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Gonadotropin-releasing hormone and its analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

The effect of long-acting analog of luteinizing hormone-releasing hormone on growth hormone secretory dynamics in children with precocious puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Combined treatment with an LHRH agonist and testosterone in man. Reversible oligozoospermia without impotence

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Prognostic value of serum hormone concentrations in prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

The effect of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. I. Uniform dosage levels

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Transient reduction in serum HDL-cholesterol following medroxyprogesterone acetate and testosterone cypionate administration to healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Inhibition of the pituitary-gonadal axis by a single intramuscular administration of D-Trp-6-LH-RH (decapeptyl) in a sustained-release formulation in patients with prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Stage dependent variation in Mn2+-sensitive adenylyl cyclase (AC) activity in spermatids and FSH-sensitive AC in sertoli cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Gonadotropin-releasing hormone analog and testosterone synergistically inhibit spermatogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Alpha-adrenoceptors and muscarinic receptors in the isolated human prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Endocrine, seminal and peripheral effects of depot medroxyprogesterone acetate and testosterone enanthate in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Pharmacokinetic characteristics of the gonadotropin-releasing hormone analog D-Ser(TBU)-6EA-10luteinizing hormone-releasing hormone (buserelin) after subcutaneous and intranasal administration in children with central precocious puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Extrapituitary Actions of Gonadotropin-Releasing Hormone*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

An analysis of the effects of changes from the assigned treatment in a clinical trial of treatment for prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Development of androgen-independent tumor cells and their implication for the treatment of prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Changes in the Metabolism of Dihydrotestosterone in the Hyperplastic Human Prostate*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Hormonal effects of single gonadotropin-releasing hormone antagonist doses in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Cyproterone acetate in treatment of precocious puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Treatment of precocious puberty with LHRH analogue in combination with cyproterone acetate-further experience

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Pubertal development, growth and final height in girls with sexual precocity after therapy with the GnRH analogue D-TRP-6-LHRH. A report on 15 girls, followed after cessation of gonadotrophin suppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Regulation of alpha and luteinizing hormone beta subunit messenger ribonucleic acids during stimulatory and downregulatory phases of gonadotropin-releasing hormone action

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Localization of testicular plasminogen activator in discrete portions (stage VII and VIII) of the seminiferous tubule

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Treatment of familial male precocious puberty with spironolactone and testolactone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Prolonged duration of gonadotropin inhibition by a third generation GnRH antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Definition of the stages of the cycle of the seminiferous epithelium in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Effects of leuprolide in the treatment of central precocious puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

The efficacy of transurethral resection of the prostate in men with moderate symptoms of prostatism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Leuprolide versus diethylstilbestrol for metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Intranasal nafarelin: an LH-RH analogue treatment of gonadotropin-dependent precocious puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Six-year results of luteinizing hormone releasing hormone (LHRH) agonist treatment in children with LHRH-dependent precocious puberty.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Effect of continuous infusion of a low dose of GnRH antagonist on serum LH and testosterone concentrations, spermatogenesis and semen quality in the rhesus monkey (Macaca mulatta).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Stimulation of spermatogenesis in stalk-sectioned rhesus monkeys by testosterone alone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Is high dosage testosterone an effective male contraceptive agent?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Failure of high-dose sustained release luteinizing hormone releasing hormone agonist (buserelin) plus oral testosterone to suppress male fertility.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Treatment of children with central precocious puberty by a slow-release gonadotropin-releasing hormone agonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Reversible azoospermia induced by an androgen-progestin combination regimen in Indonesian men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Depot leuprolide acetate for treatment of precocious puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Depot leuprolide acetate dosage for sexual precocity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Regulation of the Seminiferous Epithelium*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

1 reference

7 January 2021

Effect of deslorelin dose in the treatment of central precocious puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Comparison of the efficacy of subcutaneous and nasal spray buserelin treatment in suppression of testicular steroidogenesis in men with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Effect of MK-906, a specific 5 alpha-reductase inhibitor, on serum androgens and androgen conjugates in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Antireproductive effects of a potent gonadotropin-releasing hormone antagonist in the male rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Effect of a potent GnRH antagonist and testosterone propionate on mating behavior and fertility in the male rat

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Gonadotropin-Independent Familial Sexual Precocity with Premature Leydig and Germinal Cell Maturation (Familial Testotoxicosis): Effects of a Potent Luteinizing Hormone-Releasing Factor Agonist and Medroxyprogesterone Acetate Therapy in Four Cases*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Marked suppression of gonadotropins and testosterone by an antagonist analog of gonadotropin-releasing hormone in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Ac-D-NAL(2)1,4FD-Phe2,D-Trp3,D-Arg6-LHRH, a potent antagonist of LHRH, produces transient edema and behavioral changes in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Suppression of pituitary and testicular function in normal men by constant gonadotropin-releasing hormone agonist infusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Studies on the Role of Sex Steroids in the Feedback Control of FSH Concentrations in Men1

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Hormonal control of mammalian spermatogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Effect of chronic administration of testosterone enanthate on sperm production and plasma testosterone, follicle-stimulating hormone, and luteinizing hormone levels: a preliminary evaluation of a possible male contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

The Role of Androgens in the Initiation of Spermatogenesis in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

The feedback control of luteinizing hormone in normal adult men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Suppression of human spermatogenesis by depot androgen: Potential for male contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Ketoconazole Therapy in Advanced Prostatic Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Hormonal effects of an orally active 4-azasteroid inhibitor of 5 alpha-reductase in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Comparison of the potential for therapeutic utilities with gonadotropin-releasing hormone agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Reversible inhibition of testicular function by a gonadotropin hormone-releasing hormone antagonist in monkeys (Macaca fascicularis)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Suppression of spermatogenesis in a nonhuman primate (Macaca fascicularis) by concomitant gonadotropin-releasing hormone antagonist and testosterone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Testosterone prevents complete suppression of spermatogenesis in the gonadotropin-releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Sustained inhibition of sperm production and inhibin secretion induced by a gonadotrophin-releasing hormone antagonist and delayed testosterone substitution in non-human primates (Macaca fascicularis)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Diagnosis and management of precocious puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

The Treatment of Precocious Puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Puberty without gonadotropins. A unique mechanism of sexual development

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

The pathogenesis of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Studies on the Role of Sex Steroids in the Feedback Control of Gonadotropin Concentrations in Men. III. Androgen Resistance in Primary Gonadal Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Contraceptive efficacy of testosterone-induced azoospermia in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

Suppression of sperm function by depot medroxyprogesterone acetate and testosterone enanthate in steroid male contraception.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980158-2

7 January 2021

10.1016/S0950-351X(05)80158-2

Identifiers

DOI

1 reference

31 July 2017

1 reference